Adjuvanted vaccines for in ovo avian vaccination

Patent metadata

Field	Value
Publication number	US-9889196-B2
Application number	US-201415033793-A
Country	US
Kind code	B2
Filing date	Nov 12, 2014
Priority date	Nov 12, 2013
Publication date	Feb 13, 2018
Grant date	Feb 13, 2018

Abstract

A composition includes at least one mineral oil, a surfactant having a hydrophilic property characterized by an HLB value equal to 12 and a divalent inorganic salt intended to be used as an adjuvant in a vaccine composition for the in ovo vaccination of avian species wherein the composition is an oil-in-water emulsion or microemulsion.

First claim

The invention claimed is:

1. A vaccine for the in ovo vaccination of avian species, comprising at least one antigen and an immune adjuvant,
the at least one antigen comprising a protein selected from profilin 3-1E from Eimeiria acervulina , NetB toxin from Clostridium perfringens , or a mixture thereof,
the immune adjuvant being an oil-in-water emulsion or microemulsion comprising, for 100% of its weight:
50% to 97% of water,
1% to 45% of oily adjuvant, the oily adjuvant comprising, for 100% of its weight, 40% to 95% of at least one mineral oil and 5% to 60% of at least one surfactant, and
0.1% to 10% of at least one divalent salt.

2. The vaccine according to claim 1 , further comprising up to 10% of at least one complexing agent.

3. The vaccine according to claim 2 , wherein the at least one complexing agent is selected from the group consisting of ethylenediaminetetraacetic acid (EDTA), sodium gluconate, potassium gluconate, sodium polyacrylate, and mixtures thereof.

4. The vaccine according to claim 1 , wherein the at least one surfactant is an ethoxylated sugar ester.

5. The vaccine according to claim 1 , wherein the vaccine is effective against avian coccidiosis and/or avian necrotic enteritis.

6. The vaccine according to claim 1 , wherein the at least one divalent salt is selected from the group consisting of manganese gluconate, calcium gluconate, calcium aspartate, zinc gluconate, iron gluconate, calcium chloride, and mixtures thereof.

7. The vaccine according to claim 1 , wherein the at least one antigen is a mixture of profilin 3-1E from Eimeiria acervulina and NetB toxin from Clostridium perfringens.

8. The vaccine according to claim 1 , wherein the at least one mineral oil is a white liquid petroleum jelly of injectable quality.

9. The vaccine according to claim 1 , wherein the immune adjuvant comprises, for 100% of its weight:
80% to 97% of water,
2% to 10% of oily adjuvant, the oily adjuvant comprising, for 100% of its weight, 50% to 90% of at least one mineral oil and 10% to 50% of at least one surfactant, and
0.2% to 30% of at least one divalent salt.

10. The vaccine according to claim 9 , wherein the at least one surfactant has a Hydrophile-Lipophile Balance (HLB) value equal to 12.

11. A poultry egg, inoculated with the vaccine according to claim 1 .

12. The vaccine according to claim 1 , wherein the vaccine has been injected into the amniotic cavity of a fertilized poultry egg.

Assignees

• Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic
• Soc Dexploitation De Produits Pour Les Industried Chimiques Seppic

Inventors

• Ben Arous Juliette
• Dupuis Laurent
• Lillehoj Hyun

Classifications

• A61K2039/552

  Veterinary vaccine · CPC title

• A61K39/08

  Clostridium, e.g. Clostridium tetani · CPC title

• A61K2039/55566

  Emulsions, e.g. Freund's adjuvant, MF59 · CPC title

• A61K39/39 Primary

  characterised by the immunostimulating additives, e.g. chemical adjuvants · CPC title

• A61P37/04

  Immunostimulants · CPC title